프로프라놀롤 혈중 농도에 따른 중독환자의 임상 양상 분석
Poisoning patients’ clinical features according to the blood level of propranolol
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Propranolol is widely prescribed to psychiatric patients to control adrenergic symptoms. However, propranolol poisoning can be fatal due to cardiovascular complications. We analyzed associations between blood levels of propranolol and patients’ clinical features, with the aim of predicting progression to severe complications.Methods: Data were collected from patients aged 18 years or older who presented to the emergency department with propranolol poisoning between January 2016 and May 2022. We retrospectively analyzed their medical records and compared blood levels of propranolol between those who had cardiovascular complications and those who did not.Results: Two hundred patients were included in this study. The blood levels of propranolol were significantly higher in patients with hypotension, bradycardia, and prolonged QT intervals, with median values of 247.0 ng/mL (interquartile range [IQR], 56.5–333.8 ng/mL), 275.8 ng/mL (IQR, 154.3–486.4 ng/mL), and 159.0 ng/mL (IQR, 33.9–310.8 ng/mL), respectively. In the predictive analysis of cardiovascular complications using a receiver operating characteristic curve, the area under the curve was 0.729 with a cut-off value of 72.40 ng/mL (sensitivity, 0.667; specificity, 0.819). In addition, the correlation coefficient between blood levels and the amount of drug described during the history-taking at the time of presentation was 0.634, which was found to have a significantly higher relationship.Conclusion: Because blood levels of propranolol can be used as predictors of exacerbation in patients with propranolol poisoning, patients with blood levels above 72.40 ng/dL require careful treatment and observation from their initial presentation at the emergency department.
Abstract
Purpose: Propranolol is widely prescribed to psychiatric patients to control adrenergic symptoms. However, propranolol poisoning can be fatal due to cardiovascular complications. We analyzed associations between blood levels of propranolol and patients’ clinical features, with the aim of predicting progression to severe complications.Methods: Data were collected from patients aged 18 years or older who presented to the emergency department with propranolol poisoning between January 2016 and May 2022. We retrospectively analyzed their medical records and compared blood levels of propranolol between those who had cardiovascular complications and those who did not.Results: Two hundred patients were included in this study. The blood levels of propranolol were significantly higher in patients with hypotension, bradycardia, and prolonged QT intervals, with median values of 247.0 ng/mL (interquartile range [IQR], 56.5–333.8 ng/mL), 275.8 ng/mL (IQR, 154.3–486.4 ng/mL), and 159.0 ng/mL (IQR, 33.9–310.8 ng/mL), respectively. In the predictive analysis of cardiovascular complications using a receiver operating characteristic curve, the area under the curve was 0.729 with a cut-off value of 72.40 ng/mL (sensitivity, 0.667; specificity, 0.819). In addition, the correlation coefficient between blood levels and the amount of drug described during the history-taking at the time of presentation was 0.634, which was found to have a significantly higher relationship.Conclusion: Because blood levels of propranolol can be used as predictors of exacerbation in patients with propranolol poisoning, patients with blood levels above 72.40 ng/dL require careful treatment and observation from their initial presentation at the emergency department.
참고문헌 (28)
- Cruickshank JM, "Are we misunderstanding beta-blockers", Int J Cardiol, 120, pp.10~27 (2007)[DOI]
- clinical psychiatry, "Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences", pp.2014, MeIntyre RS
- Steenen SA, "Propranolol for the treatment of anxiety disorders : systematic review and meta-analysis", J Psychopharmacol, 30, pp.128~139 (2016)[DOI]
- Das M, "Panic disorder : propranolol and behavioural therapy", BMJ, 332, pp.1094~ (2006)[DOI]
- Hawton K, "Risk factors for suicide in individuals with depression : a systematic review", J Affect Disord, 147, pp.17~28 (2013)[DOI]
- Wax PM, "Beta-blocker ingestion : an evidence-based consensus guideline for out-of-hospital management", Clin Toxicol(Phila), 43, pp.131~146 (2005)[DOI]
- Snook CP, "Severe atenolol and diltiazem overdose", J Toxicol Clin Toxicol, 38, pp.661~665 (2000)[DOI]
- Graudins A, "Calcium channel antagonist and beta-blocker overdose : antidotes and adjunct therapies", Br J Clin Pharmacol, 81, pp.453~461 (2016)[DOI]
- Engebretsen KM, "High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning", Clin Toxicol(Phila), 49, pp.277~283 (2011)[DOI]
- Brubacher JR., "Goldfrank's toxicologic emergencies", pp.926~933 (2019), McGraw-Hill
- 주성우, "베타차단제를 포함한 정신과적 약물 중독: 심혈관계 영향을 중심으로", 대한임상독성학회지, 14(2), pp.100~106 (2016), 대한임상독성학회[DOI]
- Peet M, "The treatment of anxiety with beta-blocking drugs", Postgrad Med J, (64 Suppl 2), pp.45~49 (1988)
- Laverdure B, "Beta-blocking drugs and anxiety : a proven therapeutic value", Encephale, 17, pp.481~492 (1991)
- Love JN, "Acute beta blocker overdose : factors associated with the development of cardiovascular morbidity", J Toxicol Clin Toxicol, 38, pp.275~281 (2000)[DOI]
- Love JN, "Electrocardiographic changes associated with beta-blocker toxicity", Ann Emerg Med, 40, pp.603~610 (2002)[DOI]
- Reith DM, "Relative toxicity of beta blockers in overdose", J Toxicol Clin Toxicol, 34, pp.273~278 (1996)[DOI]
- Chen TW, "Propranolol intoxication : three cases’ experiences", Vet Hum Toxicol, 27, pp.528~530 (1985)
- Ducret F, "Deliberate self-overdose with propranolol : changes in serum levels(author’s transl)", Nouv Presse Med, 7, pp.27~28 (1978)
- Fisher ES, "Evaluation and treatment of acetaminophen toxicity", Adv Pharmacol, 85, pp.263~272 (2019)[DOI]
- Rumack BH, "Acetaminophen and acetylcysteine dose and duration : past, present and future", Clin Toxicol(Phila), 50, pp.91~98 (2012)[DOI]
- Perrone J., "Toxicologic emergencies", pp.669~674 (2019), McGraw-Hill
- Carlsson M, "Severe iron intoxication treated with exchange transfusion", Arch Dis Child, 93, pp.321~322 (2008)[DOI]
- Madiwale T, "Iron : not a benign therapeutic drug", Curr Opin Pediatr, 18, pp.174~179 (2006)[DOI]
- Adinoff B, "Acute ethanol poisoning and the ethanol withdrawal syndrome", Med Toxicol Adverse Drug Exp, 3, pp.172~196 (1988)[DOI]
- Jamaty C, "Lipid emulsions in the treatment of acute poisoning : a systematic review of human and animal studies", Clin Toxicol(Phila), 48, pp.1~27 (2010)[DOI]
- Frishman W, "Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties", Am Heart J, 97, pp.663~670 (1979)[DOI]
- Halloran TJ, "Propranolol intoxication : a severe case responding to norepinephrine therapy", Arch Intern Med, 141, pp.810~811 (1981)[DOI]
- Hong CY, "Importance of membrane stabilizing effect in massive overdose of propranolol : plasma level study in a fatal case", Hum Toxicol, 2, pp.511~517 (1983)[DOI]